Exportar Publicação
A publicação pode ser exportada nos seguintes formatos: referência da APA (American Psychological Association), referência do IEEE (Institute of Electrical and Electronics Engineers), BibTeX e RIS.
Zhang, X., Dias, Á., Pereira, L. & Silva, R. (2023). Exploring the direct and indirect effects of innovation on CSR in pharmaceutical industry in China. Progress in Industrial Ecology. 16 (4), 230-261
X. Zhang et al., "Exploring the direct and indirect effects of innovation on CSR in pharmaceutical industry in China", in Progress in Industrial Ecology, vol. 16, no. 4, pp. 230-261, 2023
@article{zhang2023_1732206038152, author = "Zhang, X. and Dias, Á. and Pereira, L. and Silva, R.", title = "Exploring the direct and indirect effects of innovation on CSR in pharmaceutical industry in China", journal = "Progress in Industrial Ecology", year = "2023", volume = "16", number = "4", doi = "10.1504/PIE.2023.135593", pages = "230-261", url = "https://www.inderscienceonline.com/doi/abs/10.1504/PIE.2023.135593" }
TY - JOUR TI - Exploring the direct and indirect effects of innovation on CSR in pharmaceutical industry in China T2 - Progress in Industrial Ecology VL - 16 IS - 4 AU - Zhang, X. AU - Dias, Á. AU - Pereira, L. AU - Silva, R. PY - 2023 SP - 230-261 SN - 1476-8917 DO - 10.1504/PIE.2023.135593 UR - https://www.inderscienceonline.com/doi/abs/10.1504/PIE.2023.135593 AB - Previous studies showed increasing evidence that large firms search for radical innovation as a driver of firm growth, particularly in the research and development sector. Proficiency at innovating via new products remains not merely a key priority for many managers but arguably the ultimate dynamic capability within a firm. However, there is limited understanding of how innovation influences CSR in pharmaceutical industry. Following a mixed methods approach, the investigation started with a review of extant literature at the intersection of intellectual property (IP), knowledge management (KM), information technology (IT), open innovation (OI), social capital (SC), innovation capability and CSR. This research adapted a quantitative approach using the structural equation modelling (SEM) statistical technique based on the variance through partial least squares (PLS). The main finding explicit that innovation capability significantly affects CSR directly, while open innovation significantly affects the innovation capability of Chinese pharmaceutical companies. ER -